Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HS3X
|
|||
| Former ID |
DIB016876
|
|||
| Drug Name |
BCH-2051
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
BioChem Therapeutic Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H22N2O5
|
|||
| Canonical SMILES |
CN(C)CCCNC(=O)C1=CC2=C(C(O1)OC)C(=O)C3=CC=CC=C3C2=O
|
|||
| InChI |
1S/C20H22N2O5/c1-22(2)10-6-9-21-19(25)15-11-14-16(20(26-3)27-15)18(24)13-8-5-4-7-12(13)17(14)23/h4-5,7-8,11,20H,6,9-10H2,1-3H3,(H,21,25)
|
|||
| InChIKey |
PFPVQJAKWPMYDX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006929) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.